Marco Moschini Selected Research

Cryotherapy (Therapy, Cold)

1/2022	Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance.
9/2021	Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy.
1/2020	Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Moschini Research Topics

Disease

118	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2014
82	Neoplasms (Cancer) 03/2024 - 06/2014
67	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 05/2013
66	Carcinoma (Carcinomatosis) 03/2024 - 06/2014
36	Non-Muscle Invasive Bladder Neoplasms 04/2024 - 04/2013
20	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2016
13	Lymphatic Metastasis 05/2023 - 02/2016
10	Margins of Excision 11/2022 - 01/2014
5	Disease Progression 12/2022 - 01/2016
5	Anemia 01/2021 - 04/2016
4	Inflammation (Inflammations) 03/2024 - 01/2020
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 08/2014
4	Fatigue 04/2023 - 01/2021
4	Carcinoma in Situ 01/2022 - 01/2017
3	Intraoperative Complications 12/2023 - 01/2022
3	Sarcopenia 04/2023 - 01/2021
3	Infections 07/2021 - 11/2017
3	Erectile Dysfunction 01/2021 - 05/2013
3	Lymphadenopathy 01/2019 - 02/2016
2	Testicular Neoplasms (Testicular Cancer) 11/2023 - 10/2021
2	Urinary Incontinence 01/2023 - 05/2013
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2023 - 01/2018
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2022 - 01/2022
2	Sepsis (Septicemia) 10/2022 - 08/2018
2	Hydronephrosis 01/2022 - 06/2019
2	Constipation 01/2021 - 01/2021
2	Febrile Neutropenia 01/2021 - 01/2021
2	Urinary Tract Infections (Urinary Tract Infection) 06/2019 - 08/2018
2	Thrombocytosis (Thrombocythemia) 12/2017 - 06/2014
2	Lymphocele 01/2017 - 01/2016
1	Cystitis 03/2024
1	Body Weight (Weight, Body) 03/2024
1	Venous Thromboembolism 03/2024
1	Urogenital Neoplasms 11/2023
1	Dysuria 05/2023

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2015
12	Prostate-Specific Antigen (Semenogelase)IBA 11/2023 - 01/2016
10	AndrogensIBA 04/2023 - 09/2015
8	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 01/2018
6	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2019
5	Gemcitabine FDA Link 02/2024 - 01/2018
5	pembrolizumabIBA 01/2024 - 12/2022
4	Carboplatin (JM8)FDA LinkGeneric 05/2023 - 01/2018
4	A-factor (Streptomyces)IBA 04/2023 - 01/2014
4	PlatinumIBA 11/2022 - 01/2018
4	AntigensIBA 10/2022 - 08/2017
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 05/2019
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2023 - 12/2020
3	Cholinesterases (Cholinesterase)IBA 07/2023 - 12/2018
3	Caveolin 1IBA 08/2022 - 01/2017
3	Cadherins (E-Cadherin)IBA 08/2017 - 01/2017
2	NivolumabIBA 02/2024 - 10/2023
2	Hormones (Hormone)IBA 04/2023 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 01/2021
2	GlobulinsIBA 01/2022 - 01/2021
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 10/2020
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2021 - 10/2020
2	Indicators and Reagents (Reagents)IBA 11/2020 - 01/2016
1	GlycosaminoglycansIBA 03/2024
1	IonsIBA 03/2024
1	Hyaluronic Acid (Hyaluronan)IBA 03/2024
1	PotassiumIBA 03/2024
1	ChondroitinIBA 03/2024
1	N(1)-methyl-2-pyridone-5-carboxylic acidIBA 11/2023
1	ElementsIBA 06/2023
1	Epirubicin (Ellence)FDA LinkGeneric 05/2023

Therapy/Procedure

101	Cystectomy 04/2024 - 01/2014
54	Therapeutics 04/2024 - 01/2016
48	Prostatectomy (Retropubic Prostatectomy) 10/2023 - 05/2013
34	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 01/2014
28	Nephroureterectomy 03/2024 - 10/2017
25	Drug Therapy (Chemotherapy) 03/2024 - 04/2013
18	Transurethral Resection of Bladder 03/2024 - 02/2019
17	Neoadjuvant Therapy 05/2023 - 02/2016
16	Radiotherapy 03/2024 - 09/2015
16	Immunotherapy 01/2024 - 09/2016
12	Adjuvant Chemotherapy 12/2022 - 01/2018
6	Blood Transfusion (Blood Transfusions) 03/2024 - 12/2015
6	Length of Stay 03/2024 - 11/2017
5	Urinary Diversion (Ileal Conduit) 09/2023 - 11/2020
3	Patient Readmission 03/2024 - 01/2016
3	Combination Drug Therapy (Combination Chemotherapy) 11/2022 - 01/2018
3	Cryotherapy (Therapy, Cold) 01/2022 - 01/2020
3	Precision Medicine 05/2021 - 01/2017
3	Nephrectomy 11/2020 - 08/2014
3	Adjuvant Radiotherapy 01/2017 - 01/2016
2	Combined Modality Therapy 03/2024 - 01/2019
2	Induction Chemotherapy 03/2024 - 05/2023
2	Organ Sparing Treatments 02/2024 - 01/2023
2	Intravesical Administration 05/2023 - 12/2020
2	Lasers (Laser) 01/2023 - 01/2018
2	Enhanced Recovery After Surgery 11/2022 - 11/2020
2	Antibiotic Prophylaxis 10/2022 - 08/2018
2	Treatment Delay 07/2022 - 01/2017
2	Minimally Invasive Surgical Procedures 01/2022 - 01/2020
2	Conservative Treatment 01/2022 - 12/2016
2	Cryosurgery 01/2020 - 01/2020
1	Operative Time 12/2023
1	MMC protocol 05/2023